SCHEMBL5862058

SCHEMBL5862058

CN(C)CCn1cc2ccc(NC(=O)CCC(=O)c3ccc(Oc4ccccc4)cc3)cc2n1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.53
MCHR1 Q99705 4/20 0.46
TERT O14746 1/20 0.44
MMP1 P03956 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CYP3A4 P08684 1/20 0.44
NOTUM Q6P988 1/20 0.44
GAA P10253 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
LTA4H P09960 1/20 0.43
GSK3B P49841 1/20 0.43
MAPT P10636 3/20 0.42
LMNA P02545 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HTT P42858 1/20 0.42
TP53 P04637 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5862817 0.90 KMT2A (0.48) POLBMCHR1TERTMEN1KMT2A
SCHEMBL5862116 0.86 MCHR1 (0.60) MCHR1TERTNOTUMGAALTA4H
SCHEMBL5862841 0.86 MCHR1 (0.60) MCHR1NOTUMLTA4H
SCHEMBL5860873 0.83 MCHR1 (0.54) MCHR1MEN1KMT2ANOTUMLTA4H
SCHEMBL5860922 0.83 MCHR1 (0.49) POLBMCHR1MEN1KMT2AMAPT
SCHEMBL5860794 0.79 MCHR1 (0.60) MCHR1NOTUMGAALTA4HMAPT
SCHEMBL6194177 0.79 NPC1 (0.51) MCHR1TERTMEN1KMT2ANOTUM
SCHEMBL5862119 0.79 MCHR1 (0.71) MCHR1LTA4H
SCHEMBL5862070 0.77 MCHR1 (0.74) POLBMCHR1MEN1KMT2ANOTUM
SCHEMBL5862808 0.76 MCHR1 (0.54) MCHR1NOTUMLTA4HMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7049307-B2 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2006-05-23 US claimed
US-20050187279-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBVIE INC. 2005-08-25 US claimed
US-20050137187-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES 2005-06-23 US claimed
US-7049307-B2 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2006-05-23 US disclosed
US-20050187279-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBVIE INC. 2005-08-25 US disclosed
US-20050137187-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137187-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R POLB 4133/4885MCHR1 1/4885TERT 3863/4885
US-20050187279-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R POLB 4133/4885MCHR1 1/4885TERT 3863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.